# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 07:30 ET
- Period: 2026-01-11
- Accession: 0001628280-26-001755
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000162828026001755/alny-20260111.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000162828026001755/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000162828026001755/alny-20260111.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-001755. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.